Influence of metabolic state and body composition on the action of pharmacological treatment of migraine
Abstract Migraine is a disabling neurovascular disorder among people of all ages, with the highest prevalence in the fertile years, and in women. Migraine impacts the quality of life of affected individuals tremendously and, in addition, it is associated with highly prevalent metabolic diseases, suc...
Main Authors: | Noor Bruijn, Romy van Lohuizen, Malgorzata Boron, Mira Fitzek, Francesca Gabriele, Giada Giuliani, Laura Melgarejo, Pavel Řehulka, Gabriele Sebastianelli, Paul Triller, Simone Vigneri, Behiye Özcan, Antoinette Maassen van den Brink, the European Headache Federation School of Advanced Studies (EHF‐SAS) |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | The Journal of Headache and Pain |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10194-024-01724-3 |
Similar Items
-
Blocking CGRP in migraine patients – a review of pros and cons
by: Marie Deen, et al.
Published: (2017-09-01) -
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
by: Valentina Favoni, et al.
Published: (2019-03-01) -
Migraine and cluster headache – the common link
by: Anne Luise Vollesen, et al.
Published: (2018-09-01) -
Triptans and CGRP blockade – impact on the cranial vasculature
by: Silvia Benemei, et al.
Published: (2017-10-01) -
Serotonergic Modulation of Neurovascular Transmission: A Focus on Prejunctional 5-HT Receptors/Mechanisms
by: Abimael González-Hernández, et al.
Published: (2023-06-01)